Johns Hopkins' James Buchanan Brady Urological Institute in fiscal 2008 received $9 million in grants from the National Cancer Institute.
Awards
Johns Hopkins' James Buchanan Brady Urological Institute in fiscal 2008 received $9 million in grants from the National Cancer Institute.
Recognition
Walsh in 2004 received the American Urological Association's highest honor, the Ramon Guiteras award.
One facet of work that connects Alan Partin, MD, to Walsh, and has made him well-known in urology academia, is the eponymous set of tables that has given thousands of men with prostate cancer worldwide a 95 percent accurate prediction of their likelihood of being cured by treatment. The Partin Tables were developed at the Brady Institute in 1993 after Partin studied the course of prostate cancer in hundreds of Walsh's radical prostatectomy patients. The tables correlate three key pieces of the prostate cancer puzzle: a man's PSA score, Gleason score, and estimated stage of cancer.
EV/pembrolizumab under review in China for advanced urothelial carcinoma
March 28th 2024The sBLA is supported by findings from the phase 3 EV-302 trial, which showed that EV/pembrolizumab extended overall survival and progression-free survival vs platinum-based chemotherapy in patients with advanced urothelial carcinoma.
Potential code for prior authorizations on AMA CPT Editorial Panel meeting agenda
March 28th 2024"Good public and economic policy must align costs, benefits, and incentives; currently, all costs are incurred by physician practices, and all financial savings and benefits from prior authorization accrue to health insurance plans, leading to perverse incentives,” says Alex Shteynshlyuger, MD.